EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aberrant CX3CL1-CX3CR1 Signaling Reprograms Microglial Exosome Secretion via KIFC2 to Drive Cognitive Impairment in Chronic Pain

Chen Hu, Xinlu Zhang, Wei Zhao, Wenjun Ke, Haoxiang Ma, Wenna Sang, Qian Gao

International Journal of Molecular Sciences · 15.07.2026 · 27 (14) · 6304

DOI: 10.3390/ijms27146304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.07.2026. Verfasst von Chen Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Anhui Medical University, Hefei 230032, China. Hauptthemen laut MEDLINE: Microglia, Chemokine CX3CL1, Exosomes, Kinesins. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Excellent Youth Scholars of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain acts as a potent driver of progressive cognitive impairment. Although microglial hyperactivation serves as a pivotal mechanistic bridge in this comorbidity, the intracellular molecular cascades coupling persistent nociception to cognitive decline remain largely elusive. Here, we identify a previously unrecognized microglial secretome remodeling axis, governed by CX3CL1-CX3CR1 signaling, that drives pain-associated cognitive impairment. Clinically, elevated cerebrospinal fluid (CSF) CX3CL1 correlates strongly with cognitive impairment in chronic pain patients. In murine models, pharmacological blockade of the microglial CX3CL1-CX3CR1 signaling attenuated chronic pain-induced memory deficits. Mechanistically, aberrant CX3CL1-CX3CR1 activation triggers a sequential p38 MAPK-NF-κB cascade to upregulate the kinesin motor KIFC2. This KIFC2 surge fundamentally reprograms microglial vesicular trafficking, driving the massive release of IL-17-enriched small exosomes (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaChemokine CX3CL1ExosomesKinesinsChronic PainCognitive DysfunctionCX3C Chemokine Receptor 1AnimalsMiceSignal TransductionMaleHumansp38 Mitogen-Activated Protein KinasesNF-kappa BMice, Inbred C57BL

Stichwörter der Autor:innen

extracellular vesiclesinterleukin-17memory deficitsneuroinflammationneurotoxicity

Substanzen

Chemokine CX3CL1KinesinsCX3C Chemokine Receptor 1p38 Mitogen-Activated Protein KinasesNF-kappa B

Autor:innen und Institutionen

  • School of Life Science, Anhui Medical University, Hefei 230032, China.

Förderung

  • Excellent Youth Scholars of Anhui Province

Zitieren

APA

Hu, C., Zhang, X., Zhao, W., Ke, W., Ma, H., Sang, W., & Gao, Q. (2026). Aberrant CX3CL1-CX3CR1 Signaling Reprograms Microglial Exosome Secretion via KIFC2 to Drive Cognitive Impairment in Chronic Pain. International Journal of Molecular Sciences, 27(14), 6304. https://doi.org/10.3390/ijms27146304

Vancouver

Hu C, Zhang X, Zhao W, Ke W, Ma H, Sang W, et al. Aberrant CX3CL1-CX3CR1 Signaling Reprograms Microglial Exosome Secretion via KIFC2 to Drive Cognitive Impairment in Chronic Pain. International Journal of Molecular Sciences. 2026;27(14):6304. doi:10.3390/ijms27146304

BibTeX
@article{Hu2026,
  author = {Hu, Chen and Zhang, Xinlu and Zhao, Wei and Ke, Wenjun and Ma, Haoxiang and Sang, Wenna and Gao, Qian},
  title = {Aberrant CX3CL1-CX3CR1 Signaling Reprograms Microglial Exosome Secretion via KIFC2 to Drive Cognitive Impairment in Chronic Pain},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6304},
  doi = {10.3390/ijms27146304}
}
Kostenlos starten →